Journal
VIROLOGY
Volume 334, Issue 1, Pages 41-50Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2005.01.015
Keywords
poxvirus; ectromelia virus; glycosylation; interferon type II; interferon gamma; interferon gamma binding protein; surface plasmon resonance
Categories
Funding
- NIAID NIH HHS [R42 AI424341-02AI] Funding Source: Medline
Ask authors/readers for more resources
Ectromelia virus (ECTV), the causative agent of mousepox, expresses an extracellular interferon-gamma binding protein (IFN-gamma BP) with homology to the ligand binding domains of the IFN-gamma high affinity receptor (IFN-gamma R1). Unlike the cellular receptor, the IFN-gamma BP binds IFN-gamma from several species. The IFN-gamma BP is synthesized early after infection, accumulating in the extracellular milieu as dimers composed of two protein species with M-r of 34.6 or 33.0 kDa. Homodimers are covalently linked by an interchain disulphide bond at position 216. The IFN-gamma BP has complex N-linked oligosaccharides at positions 41 and 149 as determined by site-directed mutagenesis and glycosidase treatment. Glycosylation at position 41 is required for secretion from mammalian cells and may play a role in the activity of the IFN-gamma BP. Glycosylation at position 149 is not required for secretion, and the lack of glycosylation at this site does not diminish ligand binding as measured by surface plasmon resonance (SPR) and ELISA. (c) 2005 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available